Vanda Pharmaceuticals Inc. (VNDA) Stock Analysis

Free AI-powered analysis and research for Vanda Pharmaceuticals Inc. stock

Sector: Healthcare

Analyze Vanda Pharmaceuticals Inc. (VNDA) Stock

Vanda Pharmaceuticals Inc. (VNDA) is a leading company in the Healthcare sector. Use StockIQ's free analysis tool to get comprehensive insights into VNDA stock performance, technical indicators, and AI-powered trading recommendations.

Get instant AI-powered analysis including technical indicators, fundamental analysis, risk assessment, and trading insights for Vanda Pharmaceuticals Inc. stock.

Analyze VNDA Now →

📰 Latest Update

Vanda Pharmaceuticals Q1 Earnings Call Highlights

Thu, May 7, 2026 at 8:18 AM UTC 3 min read

Vanda Pharmaceuticals reported its Q1 earnings, highlighting a significant increase in revenue driven by strong sales of its sleep disorder treatment, Hetlioz. The company's focus on expanding its product pipeline and addressing unmet medical needs positions it favorably for future growth. Investors should note the positive momentum in sales and the potential for upcoming product launches, which could enhance Vanda's market presence and profitability.

Read full article →